Boecking B, Rose M, Brueggemann P, Mazurek B
Foundayo (orforglipron), developed by Eli Lilly, is a new, once-daily oral GLP-1 weight-loss pill approved in the UAE (second globally after the US) and expected to be available from May 2026
Andrea Steinbrenner, a consulting executive, said she became intrigued by peptides after hearing about their benefits for "longevity, repair, anti-aging and energy," from an acquaintance who runs a clinic outside of San Diego
Use a new sterile syringe for each injection
Inositol, a common type of sugar present in the body, plays a pivotal role in speeding up metabolic processes and reducing blood cholesterol